Inquiry
Request a Quote

Prokaryotic RNA Sequencing


Overview

CD Genomics employs next-generation high-throughput sequencing technology to sequence the transcriptomes of prokaryotes (bacteria and archaea), enabling comprehensive and rapid acquisition of the complete transcriptomic information (including mRNA and non-coding RNA) from individual microbial colonies or microbial communities.

Our Advantages:
  • Comprehensive Coverage: Our platform captures both coding and non-coding regions, providing a complete transcriptome view including sRNAs, antisense transcripts, and novel regulatory elements.
  • High Sensitivity and Accuracy: Advanced rRNA depletion and high-throughput sequencing accurately detect even low-abundance transcripts, essential for understanding bacterial responses and regulatory genes.
  • Versatility Across Strains: Suitable for various bacterial strains, our service includes de novo transcriptome assembly for strains without reference genomes, facilitating the study of uncharted species.
  • Robust Bioinformatics Support: We offer extensive bioinformatics services, from initial data processing to advanced analyses like differential gene expression and pathway enrichment, ensuring high-quality, publication-ready data.

What is RNA-seq Analysis of Bacteria

RNA-seq analysis is an advanced technique for studying the bacterial transcriptome in detail. Unlike eukaryotic mRNA, bacterial mRNA lacks a poly(A) tail, requiring specialized methods for library preparation. This technique enables precise measurement of gene expression, discovery of new transcripts, and investigation of gene regulation. In prokaryotes, where transcription and translation happen simultaneously, RNA-seq captures gene expression in specific environments, helping identify key functional genes in metabolic and regulatory pathways.
The bacterial transcriptome is complex, featuring polycistronic mRNAs that encode multiple proteins. This complexity, along with the short lifespan of bacterial mRNAs and potential overlaps, demands specialized analysis tools. RNA-seq provides insights into operon structures, the role of non-coding RNAs, and the dynamics of gene expression, which are crucial for understanding bacterial physiology and pathogenicity.

Introduction to Prokaryotic RNA Sequencing

Prokaryotic RNA sequencing is a powerful, high-throughput technology designed to capture and analyze the RNA transcripts present in bacterial cells at a specific time point. Unlike eukaryotic RNA sequencing, which frequently relies on the presence of a poly(A) tail for mRNA isolation, prokaryotic RNA sequencing employs rRNA depletion methodologies to enrich for mRNA and other non-coding RNAs. This strategy enables a comprehensive analysis of the bacterial transcriptome, encompassing coding and non-coding regions, antisense transcripts, and regulatory elements.
At CD Genomics, our prokaryotic RNA sequencing platform leverages cutting-edge Illumina HiSeq (PE150) and PacBio SMRT systems to deliver high-resolution insights into bacterial gene expression. This platform is versatile, catering to both well-established strains with reference genomes and novel strains lacking genomic information. The data generated through this technology can be applied to a variety of research pursuits, including gene function annotation, differential gene expression analysis, and the elucidation of key regulatory networks within bacterial systems.

Applications of Prokaryotic RNA Sequencing

Prokaryotic RNA sequencing has a wide range of applications across various fields:

  • Microbial Physiology and Metabolism: RNA-seq enables the exploration of metabolic pathways and regulatory networks in bacteria, aiding studies of industrially significant species.
  • Pathogen-Host Interactions: Analyzing pathogenic bacteria's transcriptomes reveals infection mechanisms and antibiotic resistance, informing therapeutic and vaccine development.
  • Environmental Microbiology: Prokaryotic RNA sequencing monitors microbial communities in various habitats, enhancing understanding of bacterial adaptation and ecosystem interactions.
  • Biotechnology and Synthetic Biology: RNA-seq aids in engineering bacteria for desired traits by elucidating gene expression patterns, optimizing metabolic pathways, and enhancing bioproduct production.
Service Specifications

Prokaryotic RNA Sequencing Workflow

The prokaryotic RNA sequencing workflow at CD Genomics involves several essential steps. It begins with total RNA extraction and quality assessment, followed by rRNA depletion to enrich for mRNA and non-coding RNAs. The remaining RNA is converted to cDNA with strand specificity using dUTP, and then amplified with sequencing adapters. Sequencing is performed using either Illumina for short reads or PacBio for longer reads. Finally, CD Genomics conducts bioinformatics analysis for quality control, transcript assembly, differential gene expression analysis, and functional annotation, utilizing advanced tools like Rockhopper 2 to address the complexities of prokaryotic transcriptomes.

The Workflow of Prokaryotic RNA Sequencing.

Technical Parameters

  • HiSeq4000, PE150, >4G clean data
  • PacBio SMRT systems
  • Nanopore platform

Note: The above content includes only a portion of the bioinformatics analysis. For more information or to customize the analysis, please contact us directly.

Bioinformatics Analysis

Our bioinformatics analysis includes these parts: read QC and assembly, expression analysis, structure analysis, and advanced analysis. For more detailed bioinformatics analysis, please refer to the following table.

Read QC & Assembly
Quality assessment of raw data Contamination detection
Mapping to the reference genome De novo assembly
Structure analysis
Prediction of novel transcripts UTR analysis and annotation
SNP and indel analysis Operon analysis
sRNA analysis Prediction of antisense transcripts
Gene fusion discovery
Expression analysis
GO/KEGG enrichment analysis Cluster analysis
Gene expression quantification New gene sequence annotation
PCA Alternative splicing analysis
Advanced analysis
Metabolic pathway integration analysis Gene co-expression network analysis
Protein interaction network analysis mRNA-sRNA co-expression network analysis
Correlation analysis

Reference-based prokaryotic transcriptome analysis workflow:

The Bioinformatics Analysis pipeline of Prokaryotic RNA Sequencing.

Sample Requirement

Sample Type Recommended Quantity
Total RNA ≥ 1 µg
Cells ≥ 1×107
  • OD A260/A280 ratio ≥ 1.8, A260/230 ratio≥ 1.8, RIN ≥ 6
  • All total RNA samples should be DNA-free

Note: If you wish to obtain more accurate and detailed information regarding sample requirements, please feel free to contact us directly.

Deliverables

  • Raw sequencing data (FASTQ)
  • Clean data
  • Trimmed and stitched sequences (fasta)
  • Quality-control dashboard
  • Sample contamination report
  • Statistic data
  • Your designated bioinformatics result report
Demo

Demo

Partial results of our Prokaryotic RNA Sequencing service are shown below:

The Prokaryotic RNA Sequencing Results Display.

FAQs

Prokaryotic RNA Sequencing FAQ

Please feel free to reach out if you have any further inquiries or require additional information.

Customer Case

Customer Case

Customer Case

Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance
Journal: Antibiotics
Impact factor: 4.3
Published: 11 July 2023

Find out more

Backgrounds

In 2019, antibiotic-resistant bacteria caused 2.8 million infections and 35,000 deaths in the U.S., with A. baumannii emerging as a significant pathogen showing rapid increases in multidrug resistance. The phenomenon of adaptive efflux-mediated resistance (AEMR) allows laboratory-defined antibiotic-susceptible strains to resist treatment in host conditions. This study aimed to identify genetic determinants contributing to AEMR in A. baumannii by screening a transposon mutant library for loss of serum-associated efflux-mediated resistance.

Materials & Methods

Sample preparation:

  • Bacterial strains
  • Acinetobacter baumannii 98-37-09
  • Total RNA extraction

Method:

Data Analysis:

  • Gene expression level analysis
  • Gene Ontology (GO) analysis
  • KEGG pathway enrichment analysis
  • Classification of differentially expressed genes (DEGs)

Results

The study investigated the role of the YhaK protein in A. baumannii's adaptive efflux-mediated resistance (AEMR) by performing RNA sequencing on wild-type and YhaK-mutant cells grown in human serum. Results showed that YhaK is upregulated in serum conditions, influencing the expression of 653 genes, with notable effects on transcription, cell signaling, and transport processes. The findings suggest that YhaK may modulate AEMR through various mechanisms, potentially involving the regulation of efflux pumps and post-translational modifications, indicating its importance in A. baumannii's resistance phenotype. Additionally, mutations in YhaK could serve as a tool for further elucidating the genetic determinants of AEMR in this pathogen.

Figure 1. Transcriptome analysis of A. baumannii WT and YhaK Tn: KEGG gene ontology categories. (Young et al., 2023)Figure 1. A. baumannii WT and YhaK Tn Transcriptome analysis: KEGG gene ontology groups.

Figure 2. Transcriptome analysis of A. baumannii WT and YhaK Tn: genes with differential expression. (Young et al., 2023)Figure 2. A. baumannii WT and YhaK Tn Transcriptome analysis: differentially expressed genes.

Conclusions

The antibiotic resistance of Acinetobacter baumannii is predominantly attributed to mutations that result in the overexpression of one or more of its 40 putative efflux pump systems. This study significantly contributes to the understanding of the molecular mechanisms underlying efflux pump-mediated antibiotic resistance in A. baumannii, and it holds substantial implications for the future development of antibiotics and antimicrobial therapies.

Reference

  1. Young M, Chojnacki M, Blanchard C, et al. Genetic Determinants of Acinetobacter baumannii Serum-Associated Adaptive Efflux-Mediated Antibiotic Resistance. Antibiotics. 2023, 12(7):1173.

* For Research Use Only. Not for use in diagnostic procedures or other clinical purposes.



Copyright © 2024 CD Genomics. All rights reserved. Terms of Use | Privacy Notice